Medicure Inc. MCUJF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 11.32% | 51.61% | 45.51% | 56.79% | 27.70% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 11.32% | 51.61% | 45.51% | 56.79% | 27.70% |
| Cost of Revenue | 30.72% | 75.33% | 169.27% | 126.58% | 44.52% |
| Gross Profit | -6.94% | 29.57% | -27.10% | -1.90% | 15.08% |
| SG&A Expenses | 16.16% | 8.37% | 82.17% | 5.45% | 4.80% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 19.12% | 41.69% | 109.99% | 48.60% | 15.98% |
| Operating Income | -93.49% | 41.39% | -1,792.38% | -12.12% | 38.16% |
| Income Before Tax | -89.34% | 36.69% | -867.54% | -295.55% | 34.96% |
| Income Tax Expenses | -15.51% | -75.09% | -59.04% | 1,335.14% | -47.89% |
| Earnings from Continuing Operations | -81.61% | 38.79% | -666.51% | -303.29% | 36.13% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -81.61% | 38.79% | -666.51% | -303.29% | 36.13% |
| EBIT | -93.49% | 41.39% | -1,792.38% | -12.12% | 38.16% |
| EBITDA | -1,288.83% | 2,312.50% | -2,121.77% | -25.73% | 89.86% |
| EPS Basic | -81.80% | 38.66% | -665.44% | -303.14% | 36.15% |
| Normalized Basic EPS | -89.52% | 36.86% | -2,557.35% | -11.54% | 34.92% |
| EPS Diluted | -74.91% | 40.16% | -665.44% | -303.14% | 34.09% |
| Normalized Diluted EPS | -89.52% | 36.40% | -2,557.35% | -11.54% | 34.92% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | -0.57% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |